Deal overview
| Target | STADA ARZNEIMITTEL AG |
|---|---|
| Bidder | BAIN CAPITAL LLC/ CINVEN LIMITED |
| Price | £90.00 Full version or £25.00 Light version |
| Publication Date | Oct 01, 2018 |
| Abstract | On 1 October 2018, Nidda Healthcare GmbH ("Nidda Healthcare"), an acquisition vehicle jointly owned by the private equity firms Cinven Limited ("Cinven") and Bain Capital LLC ("Bain Capital"), announced that it intended to make a public delisting offer the remaining 34.69% stake it did not already own in the quoted German pharmaceutical company STADA Arzneimittel AG ... |
| Number of pages (Full version) | 9 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
